Kiromic BioPharma
cell therapy multiple potential indications non viral non non viral non engineered engineered off the shelf off the shelf product product candidate candidate targeting stress targeting stress on on cancer cells cancer cells | Kiromic BioPharma
Company
Deck Type
Sector
Industry
Deck date
May 2023
Slide
12 of 25
Related slides by other companies
Nuvalent
Investor Presentation
August 2023
targeted therapies for patients with cancer resistance | Nuvalent
Nuvalent
Investor Presentation
May 2023
targeted therapies for patients with cancer resistance | Nuvalent
Genprex
Investor Presentation
October 2022
investment highlights | Genprex
Nuvalent
Investor Presentation
October 2023
targeted therapies for patients with cancer resistance | Nuvalent
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights